Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Any definite and reliable source for theses 100 Bil. A/S? Somebody seems to have control over the company all the time.
Interesting. Sylios seems to be in the same position. That would put both explorers in a position to work together in this field. they could achieve much more, and could also produce much more, as when staying alone. That' why they signed the cooperation.
It'll get more substantial, when they can deliver their gas through the pipelines to the gas cleaning facilities and the consumers.
Good evening, I hope also, that they will keep shareholders updated with news about the new pipeline.
I had an e*trade account before, and faced no issues. The reverse split sometimes, especially with OTC listed stockes, may cause some organazing issues for the DTC and brokers/banks, but I would guess that an american broker can act much quicker than a foreign one.
Reading something fine about studies with tesetaxel probably. Not sure about the stock.
Hhhm, probably because of the "foreign status" in Canada for Bayport shares.
Have your shares been locked for 3 weeks after the reverse split? that's indeed a long time.
Yes, after the decline we could expect some improvement in pps again.
Worthless, "so fair", sounds interesting.
But so far no news.
Ceap shares are still available.
GE business is more related to industrial und financials applications nowadays.
At least another new poster with good arguments. Welcome.
I would agree with respect of bad historic decline in pps as long this stock was under EXTO, Exit Only. The share exchange for affected shareholders to BAYP, and the possibility to buy back shares at a considerable low price during the last one and half year, together with a considerable interesting business development, with new cooperations on the way, gave new hope. There was already a uptrend in February.
Still some decline, but volume rather low. But volume is somewhat higher compared to days after the financial transaction.
Yes, my friend, I have some worthless shares not booked out in my account, still visable. What can we do that these shares can be booked out with with value?
They probably have a R/S ?
Who was that "someone". He might be wrong. It is already a long time off market
Who was that "someone". He might be wrong. It is already a long time off market
unfortunately we have adowntrend today, but i would think, that ppl who know the potential, will stay or buy even some more.
This is what investors can hope. But arrangement of a pipeline building projet is not done within one day.
It is nor clear, that Genta transferred the rights, because GFV is only assignee. There can be more than one assignee to whom they can transfer the rights.
GFV LLC is thus able to step in this business by producing a much desired compound by an own developed process. They can of course arrange a cooperation with an external company to let the compounds produce described after the procedure in the patent.
I think it's not the numbers of players alone. It is mostly, what price these players are offering for their shares. MM will buy them back, if he only gets offers with the same price (and he does not offer his own shares).
GE, that's not a penny.
Maybe just because too less people read these news. They contain at least a positive outlook. But for a definite production start with these two new wells it is yet too early. Some work still has to be done, but I would expect that they can manage that within one or two months.
Yes, really, I agree. I'm wondered, that pps is not in more uptrend. This news are promising, and it seems to me that they are on the right way.
Compared to GFV LLC, which have already taken a valid patent for the tesetaxel synthesis, Genta is behind. But this isn't an issue, because it's the priority date, which counts always first, when a patent was applied for.
Interesting
Thank you for the link to these interesting news, but I have read them already some days ago. I'm wondered that GE intends to give up a very traditional business segment.
I don't know the date of publishing either, but in case of the patents this depends if the trustees are willing to pay for the examination process of the patent applications. These infos on patents are freely available by the patent office, when the patent is issued.
You probably have these information out of the register at clinicaltrials.gov. The end of the studies given is the scheduled end, when the data were put in the database. The records in the database need to be updated by someone, who is in charge of confirming these datas (should be the trustees right now). Therefore, if there was any delay, the later end of the studies is not yet given. But if the studies are well organized, and the trustee keep an eye on them, then the scheduled end might become the definite end.
Jugde Kevin Gross might put this case back on this table, when he see the results of the Tesetaxel studies.
For the Reverse you are one month too late. Next time it will be a forward.
What me wonders, if these studies are finished, that the court has any influence on it. I would guess, that the trustee(s), there are already two of them, are in charge of organising those studies even after the company went bankruptcy. The court seems only to have a look on it, if the studies are organized in a "right manner". At least Tesetaxel has a bigger importance for public health.
Me, too, have no idea what they are waiting for. Probably nobody has paid the court fees yet.
Interesting. Japan, despite the Fukushima desaster, tries to get a foot in more "green energy"
What if they use the new shares for a share exchange program?
Which way could the bancruptcy court choose to publish its decisions?
Should we all phone the Porters at their office next week? They might publish new favorable results. The cooperation with Sylios probably will bring some fruits to the company.